Page 15 - Flipbook
P. 15
“Systemic” therapies by biologic domain in advanced Prostate Cancer
‘Enhanced’ Targeted Agents
Androgen signaling Chemotherapy Immunotherapy Radioligand Precision
Agents
inhibition Therapy
Abiraterone Acetate Sipuleucel T
Enzalutamide Docetaxel Pembrolizumab Radium-223 Olaparib
Apalutamide Cabazitaxel Lu-PSMA Rucaparib
Darolutamide
Abi + Apa Ipatasertib
Treatment of Primary
A systemic (equivalent) therapy ?
Source: Personal File
Grey Listings: phase III data but no indication (yet)
